Healthy adults
Conditions
Interventions
Duration: 12 weeks Test material: KIMIE WHITE 6 (three times) tablets per day
Duration: 12 weeks Test material: CYSTATHIONE 2 capsules per day (940mg/day)
Duration: 12 weeks Test material: Pl
Sponsors
ORTHOMEDICO Inc.
Seishin-kai Medical Association Inc, Takara Medical Clinic.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: a) Women who are between 40 and 59 years old b) Persons who are bothering about freckles or ephelides on skin
Exclusion criteria
Exclusion criteria: a) Persons who have previous medical history of malignancy, heart failure, or myocardial infarction b) Patients being treated for at least one of following diseases; atrial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, and other chronic disease c) Persons who take medicines, herbal medicines, or dietary supplements d) Persons who are allergic to medicines, or foods related to the test material of this trial e) Persons who have previous medical history of pollinosis f) Persons who take dietary supplements or enriched foods g) Pregnant women, lactating women, or women who want to get pregnant during the trial period h) Persons who have been enrolled in the other clinical trials within last 3 months before the agreement for the participation to this trial i) Persons who are judged not suitable to participate in this trial by physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin assessment (Robo Skin Analyzer) + fluid + lipids + brightness + number of pigmentation + area of pigmentation + number of pores + number of wrinkle + total length of wrinkle + total area of wrinkle + skin texture | — |
Secondary
| Measure | Time frame |
|---|---|
| Subjective symptoms measured by Likert scales. | — |
Countries
Japan
Contacts
Public ContactNaoko SUZUKI
ORTHOMEDICO, Inc. R&D Department
Outcome results
None listed